4-chloro-6-propylthio-pyrimidine | 263276-29-5

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 4-chloro-6-propylthio-pyrimidine
• 英文别名: Pyrimidine, 4-chloro-6-(propylthio)-；4-chloro-6-propylsulfanylpyrimidine
• CAS: 263276-29-5
• 化学式: C₇H₉ClN₂S
• 分子量: 188.681
• InChiKey: CIONINBHIOKBHW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  51.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-chloro-6-propylthio-pyrimidine 在 lithium hydroxide 、 N,N-二异丙基乙胺 、 间氯过氧苯甲酸 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 生成 S-3-[4-(3,5-dichloropyrid-4-ylcarboxamido)-phenyl]-2-(6-propylsulphonylpyrimidin-4-ylamino)propanoic acid
  参考文献：
  名称：

  N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists

  摘要：

  The SAR studies to optimise both potency and rate of clearance in the rat for a series of pyrimidine and pyridine based VLA-4 antagonists are described. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00241-x
• 作为产物：
  描述：

  N-isonicotinoyl-(L)-4-aminophenylalanine 生成 4-chloro-6-propylthio-pyrimidine
  参考文献：
  名称：

  N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists

  摘要：

  The SAR studies to optimise both potency and rate of clearance in the rat for a series of pyrimidine and pyridine based VLA-4 antagonists are described. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00241-x

文献信息

• Phenylalanine derivatives
  申请人：Celltech Therapeutics Limited

  公开号：US06348463B1

  公开（公告）日：2002-02-19

  Phenylalanine derivatives of formula (1) are described: in which: Ar1 is an aromatic or heteroaromatic group; L1 is a linker atom or group; R is a carboxylic acid or a derivative thereof; Ar2 is an optionally substituted aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are able to inhibit the binding of &agr;4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.

  公式（1）的苯丙氨酸衍生物如下所述： 其中： Ar1是芳香族或杂环芳基； L1是连接原子或基团； R是羧酸或其衍生物； Ar2是可选择取代的芳香族或杂环芳基； 以及它们的盐、溶剂合物、水合物和N-氧化物。 这些化合物能够抑制α4整合素与其配体的结合，并可用于预防和治疗免疫或炎症性疾病。
• Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
  申请人：——

  公开号：US20020086882A1

  公开（公告）日：2002-07-04

  Disclosed are a series of heteroaryl-&bgr;-alanine derivatives, compositions containing them, processes for their preparation and their use in medicine.

  揭示了一系列杂环芳基-β-丙氨酸衍生物，包含它们的组合物，其制备方法以及在医学中的应用。
• Phenylalanine derivatives as alpha 4 integrin inhibitors
  申请人：——

  公开号：US20020055509A1

  公开（公告）日：2002-05-09

  Disclosed are a series of phenylalanine derivatives, to compositions containing them, to processes for their preparation, and to their use in medicine.

  本发明涉及一系列苯丙氨酸衍生物，涉及含有它们的组合物，涉及它们的制备过程以及它们在医学中的使用。
• N-Aryl 2,6-Dimethoxybiphenylalanine Analogues as VLA-4 Antagonists
  作者：George A Doherty、Theodore Kamenecka、Ermenegilda McCauley、Gail Van Riper、Richard A Mumford、Sharon Tong、William K Hagmann

  DOI：10.1016/s0960-894x(02)00009-4

  日期：2002.3

  A series of N-arylated phenylalanine derivatives has been synthesized and has been shown to be potent inhibitors of the integrin VLA-4. N-phenyl and N-heteroaryl derivatives with hydrogen bond acceptors in the meta position demonstrated low nanomolar activity against VLA-4. (C) 2002 Elsevier Science Ltd. All rights reserved.
• PHENYLALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
  申请人：CELLTECH THERAPEUTICS LIMITED

  公开号：EP1117657A1

  公开（公告）日：2001-07-25